InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,625.80
(
0.16%
)
US TECH 100
19,010.00
(
-0.02%
)
Dow Jones
41,250.50
(
0.02%
)
Brent Oil
78.70
(
-0.37%
)
Bitcoin
59,265.18
(
-0.39%
)
Post# of 26138
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Deut8184Me

Send PM Follow Ignore
Followers 3
Posts 57
Boards Moderated 0
Alias Born 02/04/2012

Deut8184Me

Re: grawsha post# 12863

Monday, 02/27/2012 11:17:39 AM

Monday, February 27, 2012 11:17:39 AM

Post# of 26138
This news alone should have doubled the pps...The Food and Drug Administration has awarded the therapy orphan drug status, which means BioSante may be able to conduct faster studies of the drug and if it is approved, the company will have years of marketing exclusivity..........
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up